The effect of gemigliptin treatment on immune parameters including regulatory T cells in patients with type 2 diabetes and moderate to very severe chronic renal impairment.

MLA

Kim, Yanghyeon, et al. “The Effect of Gemigliptin Treatment on Immune Parameters Including Regulatory T Cells in Patients with Type 2 Diabetes and Moderate to Very Severe Chronic Renal Impairment.” Medicine, vol. 102, no. 49, Dec. 2023, p. e36455. EBSCOhost, https://doi.org/10.1097/MD.0000000000036455.

APA

Kim, Y., Lee, N., Heo, S., Kim, Y. N., Shin, H. S., Jung, Y., & Rim, H. (2023). The effect of gemigliptin treatment on immune parameters including regulatory T cells in patients with type 2 diabetes and moderate to very severe chronic renal impairment. Medicine, 102(49), e36455. https://doi.org/10.1097/MD.0000000000036455

Chicago

Kim, Yanghyeon, Nagyeom Lee, Sujung Heo, Ye Na Kim, Ho Sik Shin, Yeonsoon Jung, and Hark Rim. 2023. “The Effect of Gemigliptin Treatment on Immune Parameters Including Regulatory T Cells in Patients with Type 2 Diabetes and Moderate to Very Severe Chronic Renal Impairment.” Medicine 102 (49): e36455. doi:10.1097/MD.0000000000036455.